KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Takeda Pharmaceutical (TAK) Current Assets (2018 - 2026)

Takeda Pharmaceutical has reported Current Assets over the past 9 years, most recently at $19.7 billion for Q1 2026.

  • For Q1 2026, Current Assets rose 19.25% year-over-year to $19.7 billion; the TTM value through Mar 2026 reached $19.7 billion, up 19.25%, while the annual FY2026 figure was $20.5 billion, 24.04% up from the prior year.
  • Current Assets was $19.7 billion for Q1 2026 at Takeda Pharmaceutical, up from $16.5 billion in the prior quarter.
  • Across five years, Current Assets topped out at $22.3 billion in Q1 2022 and bottomed at $16.5 billion in Q1 2025.
  • The 5-year median for Current Assets is $18.1 billion (2023), against an average of $18.8 billion.
  • Year-over-year, Current Assets dropped 18.77% in 2023 and then increased 19.25% in 2026.
  • Over 5 years, Current Assets stood at $22.3 billion in 2022, then dropped by 18.77% to $18.1 billion in 2023, then dropped by 4.76% to $17.3 billion in 2024, then decreased by 4.28% to $16.5 billion in 2025, then increased by 19.25% to $19.7 billion in 2026.
  • The last three reported values for Current Assets were $19.7 billion (Q1 2026), $16.5 billion (Q1 2025), and $17.3 billion (Q1 2024) per Business Quant data.